Even women with more severe MS cases are less likely than men to get critical treatments, a new study finds. Women under age 40 with multiple sclerosis are 8 percent less likely than men to receive ...

Sales of Biogen’s BIIB key multiple sclerosis (“MS”) drugs like Tecfidera and Tysabri and spinal muscular atrophy (SMA) treatment, Spinraza, are being hurt due to competitive pressure, which is ...

The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), Alzheimer's, and Parkinson's disease continues to rise, especially for MS ...

Ongoing clinical trials are exploring therapies like tolebrutinib, fingolimod, and ocrelizumab, focusing on efficacy and ...

Nearly 80% of US neurologists prescribing drugs for multiple sclerosis (MS) received at least one pharma industry payment, with higher volume prescribers more likely to be beneficiaries, finds a 5 ...

A new study found that most therapies used to treat multiple sclerosis (MS) were linked to a higher risk of low birth weight but not miscarriage, premature birth, and major birth defects. The study ...

Drugs currently used to treat Type 2 diabetes may also prove useful for treatment of multiple sclerosis, according to studies at the University of Illinois at Chicago and the West Side Veterans ...

MINNEAPOLIS – Certain medications for multiple sclerosis (MS) called monoclonal antibodies, taken while breastfeeding, may not affect the development of a child during the first three years of life, ...

Breastfeeding by women with multiple sclerosis (MS) or neuromyelitis optica spectrum disorder who are taking monoclonal antibodies (mAbs) appears to be safe for infants, new research confirmed. "Most ...

Many women are diagnosed with multiple sclerosis (MS) at an age when they are considering starting a family. What does the disease and its medication mean for the child? To answer this question, a ...